Text Size

Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2005 by United States Naval Medical Center, San Diego.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
United States Naval Medical Center, San Diego
ClinicalTrials.gov Identifier:
NCT00134797
First received: August 24, 2005
Last updated: November 4, 2005
Last verified: August 2005
History of Changes
  Purpose

The addition of an estimate value of glomerular filtration rate (GFR) per Modification of Diet in Renal Disease [MDRD] (LEVEY) equation is being included and reported on all routine chemistry panels in the experimental group. The control group is only having serum creatinine, the current standard of care, reported on routine chemistry panels.


Condition
Chronic Kidney Disease

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: The Effect of MDRD GFR Reporting on Nephrology Referral Patterns by Internists

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by United States Naval Medical Center, San Diego:

Estimated Enrollment: 1500
Study Start Date: February 2005
Estimated Study Completion Date: February 2006
Detailed Description:

All patients already referred to or being followed by nephrologists were excluded. Inclusion criteria were all patients in the Internal Medicine clinic at NMCSD who were sent to the lab to obtain routine chemistry panels for follow up by their primary care providers. The primary outcome is increased referral to nephrology in accordance with NKF K/DOQI guidelines if GFR values are reported on routine chemistry panels. Key secondary outcomes are Primary Care Provider knowledge of NKF K/DOQI guidelines, specifically when patients with chronic kidney disease need to be referred to a nephrologist for further evaluation.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All patients in the Internal Medicine Clinic at Naval Medical Center, San Diego (NMCSD) who were sent to the lab to obtain follow up by their primary care providers.

Exclusion Criteria:

  • All patients referred to or being followed by nephrologists.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00134797

Contacts
Contact: Heather J Miller, M.D. HJMiller1@nmcsd.med.navy.mil

Locations
United States, California
Naval Medical Center San Diego Recruiting
San Diego, California, United States, 92134
Contact: Heather J Miller, M.D.         HJMiller1@nmcsd.med.navy.mil    
Principal Investigator: Heather J Miller, M.D.            
Sponsors and Collaborators
United States Naval Medical Center, San Diego
Investigators
Principal Investigator: Heather J Miller, M.D. United States Naval Medical Center, San Diego
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00134797     History of Changes
Other Study ID Numbers: CIP #S-04-058
Study First Received: August 24, 2005
Last Updated: November 4, 2005
Health Authority: United States: Federal Government

Keywords provided by United States Naval Medical Center, San Diego:
GFR
serum creatinine

Additional relevant MeSH terms:
Kidney Diseases
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency

ClinicalTrials.gov processed this record on May 16, 2013